Raymond James & Associates’s Alector ALEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-112,859
Closed -$1.15M 3943
2022
Q2
$1.15M Buy
112,859
+35,259
+45% +$352K ﹤0.01% 2351
2022
Q1
$1.11M Buy
+77,600
New +$1.23M ﹤0.01% 2522
2021
Q2
Sell
-33,670
Closed -$678K 4089
2021
Q1
$678K Sell
33,670
-34,535
-51% -$619K ﹤0.01% 2781
2020
Q4
$1.03M Buy
68,205
+38,629
+131% +$480K ﹤0.01% 2327
2020
Q3
$312K Buy
+29,576
New +$478K ﹤0.01% 2937
2020
Q2
Sell
-8,812
Closed -$213K 3516
2020
Q1
$213K Buy
+8,812
New +$225K ﹤0.01% 2995

Other funds holding ALEC

Raymond James & Associates's ALEC Position: Q3 2022 in Review

Raymond James & Associates sold out of Alector (ALEC) in Q3 2022, closing a stake of 112,859 shares — an estimated $1.15M sold.

Raymond James & Associates first reported a position in ALEC in Q1 2020 and held it in 6 quarters. The position peaked at $1.15M in Q2 2022. 168 funds tracked by Wall St. Rank hold ALEC as of Q3 2022.

  • Raymond James & Associates reported no remaining Alector position as of Q3 2022 after selling out during the quarter.
  • Raymond James & Associates sold 112,859 Alector shares in Q3 2022, an estimated $1.15M.
  • Raymond James & Associates first reported a position in Alector in Q1 2020 and held it in 6 quarters.
  • Raymond James & Associates's Alector position peaked at $1.15M in Q2 2022.
  • 168 funds tracked by Wall St. Rank held Alector as of Q3 2022.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.